Chapter 145 - Acute DVT introduction Flashcards
DVT Epidemiology
Men > woman Higher in Hispanic, asian/pacific islanders
In hospital patients with highest risk of DVT
1) acute spinal cord injury 2) trauma 3) neurosurgery 4) ICU patients 5) major orthopedic 6) ward patients
Risk factors of DVT
1) hospitalization 2) surgery 3) trauma 4) cancer 5) chemotherapy 6) varicose veins at young < 60 age 7) congestive heart failure 8) age
Caprini score for DVT risk
FIGURE 145.1
Incidence of DVT from age 30 to age 80
increase 30 fold
Other risks that increase with age and therefore predispose DVT
1) acquired prothrombotic state (higher thrombin) 2) increased stasis in venous valve pockets 3) anatomical changes in soleal veins 4) increase biological markers
Typical clinical scenario in children who acquire VTE
1) scoliosis with halo-femoral traction immobolization 3.7% 2) ICU admission 4% 3) spinal cord injury 10%
Immobilization risk for DVT time line
Increases at 3 days very high risk after 2 weeks
Risk factors for getting DVT in travels
1) no compression stocking 10% risk 2) > 5000 km (150x risk) 3) previous VTE (OR 63.3) 4) trauma (13.6) 5) varicose veins (10) 6) obesity (9.6) 7) immobility during flight (9.3) 8) cardiac disease (8.9)
DVT presented that were recurrences (%)
23-26%
Risk of recurrent DVT with heterozygous factor V Leiden
40% at 8 years 2.4x higher than normal
Percentage of recurrent DVT due to hyperhomocysteinemia
17%
Percentage of first time VTE associated with malignancy
20% 4x higher risk than those without cancer
Cancer types associated with highest VTE risk
1) pancreas ++ 2) kidney 3) ovary 4) lung 5) stomach
Mechanisms in which cancer may increase VTE
1) mass effect venous compression 2) thrombocytosis 3) immobility 4) indwelling central lines 5) chemotherapy 6) radiation therapy 7) Tumor increase TF expression –> activate FX and XI –> thrombin 8) cancer procoagulant –> activate FX 9) platelet adhesion to tumor cells via glycoprotein Ib and IIb/IIIa
Difference between TF and CP in activating factor X
TF requires FVII CP activates X without FVII
How does IL-1 and TNF alpha cause VTE
1) downregulate thrombomodulin (thrombin receptor) on endothelial surface –> decrease thrombin-thrombomodulin complex –> decrease protein C activation 2) stimulate PAI-1 production –> inhibit fibrinolysis
Most common abnormalities in coagulation parameter in cancer
1) elevated fibrinogen 2) thrombocytosis 3) elevated coagulation factor 4) elevated fibrin degradation product 5) lower protein C and S
Coagulation peptide that reflect tumor activity
Fibrinopeptide A
Risk of DVT in treatment for non-Hodgkin’s lymphoma
6%